The FDA have recently released new policy documents that cover the development and oversight of innovative digital health tools. Linked below is the document that would relate to RAP. Some investors might find it useful for helping understanding the evolving FDA process.
https://www.fda.gov/downloads/Medic...onandGuidance/GuidanceDocuments/UCM524904.pdf
